FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity.
about
Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy.EDIL3 depletion suppress epithelial-mesenchymal transition of lens epithelial cells via transforming growth factor β pathway.Tropomyosin 2 heterozygous knockout in mice using CRISPR-Cas9 system displays the inhibition of injury-induced epithelial-mesenchymal transition, and lens opacity.The Antimicrobial Peptide Nal-P-113 Exerts a Reparative Effect by Promoting Cell Proliferation, Migration, and Cell Cycle Progression
P2860
FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FGF2 antagonizes aberrant TGFβ ...... for posterior capsule opacity.
@en
FGF2 antagonizes aberrant TGFβ ...... for posterior capsule opacity.
@nl
type
label
FGF2 antagonizes aberrant TGFβ ...... for posterior capsule opacity.
@en
FGF2 antagonizes aberrant TGFβ ...... for posterior capsule opacity.
@nl
prefLabel
FGF2 antagonizes aberrant TGFβ ...... for posterior capsule opacity.
@en
FGF2 antagonizes aberrant TGFβ ...... for posterior capsule opacity.
@nl
P2093
P2860
P356
P1476
FGF2 antagonizes aberrant TGFβ ...... for posterior capsule opacity.
@en
P2093
Dhirendra P Singh
Etsuko Kiyokawa
Hiroshi Sasaki
Shinsuke Shibata
Teppei Shibata
P2860
P304
P356
10.1111/JCMM.13030
P577
2016-12-15T00:00:00Z